KR930001410B1 - 치환된 벤즈이미다졸 유도체의 제조방법 - Google Patents

치환된 벤즈이미다졸 유도체의 제조방법 Download PDF

Info

Publication number
KR930001410B1
KR930001410B1 KR1019850008129A KR850008129A KR930001410B1 KR 930001410 B1 KR930001410 B1 KR 930001410B1 KR 1019850008129 A KR1019850008129 A KR 1019850008129A KR 850008129 A KR850008129 A KR 850008129A KR 930001410 B1 KR930001410 B1 KR 930001410B1
Authority
KR
South Korea
Prior art keywords
chloro
formula
benzimidazole
piperidino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019850008129A
Other languages
English (en)
Korean (ko)
Other versions
KR860004050A (ko
Inventor
죤 이훼 로버트
Original Assignee
스미스 클라인 앤드 프렌취 라보라토리스 리미티드
데비드 마틴 워터스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848427836A external-priority patent/GB8427836D0/en
Priority claimed from GB848432515A external-priority patent/GB8432515D0/en
Priority claimed from GB858518043A external-priority patent/GB8518043D0/en
Application filed by 스미스 클라인 앤드 프렌취 라보라토리스 리미티드, 데비드 마틴 워터스 filed Critical 스미스 클라인 앤드 프렌취 라보라토리스 리미티드
Publication of KR860004050A publication Critical patent/KR860004050A/ko
Application granted granted Critical
Publication of KR930001410B1 publication Critical patent/KR930001410B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019850008129A 1984-11-02 1985-11-01 치환된 벤즈이미다졸 유도체의 제조방법 Expired - Fee Related KR930001410B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB848427836A GB8427836D0 (en) 1984-11-02 1984-11-02 Chemical compounds
GB8427836 1984-11-02
GB848432515A GB8432515D0 (en) 1984-12-21 1984-12-21 Heterocyclic compounds
GB8432515 1984-12-21
GB8518043 1985-07-17
GB858518043A GB8518043D0 (en) 1985-07-17 1985-07-17 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
KR860004050A KR860004050A (ko) 1986-06-16
KR930001410B1 true KR930001410B1 (ko) 1993-02-27

Family

ID=27262502

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850008129A Expired - Fee Related KR930001410B1 (ko) 1984-11-02 1985-11-01 치환된 벤즈이미다졸 유도체의 제조방법

Country Status (19)

Country Link
EP (1) EP0184322B1 (enExample)
KR (1) KR930001410B1 (enExample)
CN (1) CN1013445B (enExample)
AR (1) AR241592A1 (enExample)
AU (1) AU576634B2 (enExample)
CA (1) CA1253150A (enExample)
DE (1) DE3574873D1 (enExample)
DK (1) DK501085A (enExample)
ES (1) ES8701752A1 (enExample)
FI (1) FI84718C (enExample)
GR (1) GR852643B (enExample)
HU (1) HU200763B (enExample)
IE (1) IE58587B1 (enExample)
JO (1) JO1406B1 (enExample)
NO (1) NO164541C (enExample)
NZ (1) NZ214024A (enExample)
PH (1) PH22303A (enExample)
PT (1) PT81420B (enExample)
ZW (1) ZW19185A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
GB8610607D0 (en) * 1986-04-30 1986-06-04 Smith Kline French Lab Chemical compounds
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
JPH09509143A (ja) * 1993-12-01 1997-09-16 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノアルキルアミノピリジン
YU86001A (sh) 1999-06-07 2004-07-15 Altana Pharma Ag. Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
EP2145888A1 (en) 2003-09-18 2010-01-20 Conforma Therapeutics Corporation Deazapurine derivatives as HSP90-Inhibitors
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
BRPI0609509A2 (pt) * 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
EP0178438A1 (en) * 1984-09-19 1986-04-23 Beecham Group Plc Novel compounds
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76837A0 (en) * 1984-10-31 1986-02-28 Byk Gulden Lomberg Chem Fab Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
FI864138A7 (fi) * 1985-10-16 1987-04-17 Fisons Plc Heterocykliska blandningar.
EP0806002A1 (en) * 1995-11-24 1997-11-12 Koninklijke Philips Electronics N.V. A method for presenting virtual reality enhanced with tactile stimuli, and a system for executing the method

Also Published As

Publication number Publication date
FI854267A0 (fi) 1985-10-30
JO1406B1 (en) 1986-11-30
HU200763B (en) 1990-08-28
DK501085D0 (da) 1985-10-31
CN85108133A (zh) 1986-04-10
ES548409A0 (es) 1986-12-01
AU4920785A (en) 1986-05-08
HUT39176A (en) 1986-08-28
ZW19185A1 (en) 1986-05-21
NO164541C (no) 1990-10-17
EP0184322B1 (en) 1989-12-20
IE852684L (en) 1986-05-02
GR852643B (enExample) 1986-03-05
DK501085A (da) 1986-05-03
CN1013445B (zh) 1991-08-07
KR860004050A (ko) 1986-06-16
FI854267L (fi) 1986-05-03
AR241592A1 (es) 1992-09-30
IE58587B1 (en) 1993-10-06
FI84718B (fi) 1991-09-30
PT81420B (pt) 1988-05-27
PH22303A (en) 1988-07-22
AU576634B2 (en) 1988-09-01
FI84718C (fi) 1992-01-10
CA1253150A (en) 1989-04-25
PT81420A (en) 1985-11-01
NO854369L (no) 1986-05-05
NO164541B (no) 1990-07-09
EP0184322A1 (en) 1986-06-11
DE3574873D1 (en) 1990-01-25
ES8701752A1 (es) 1986-12-01
NZ214024A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
KR930001410B1 (ko) 치환된 벤즈이미다졸 유도체의 제조방법
JP4533466B2 (ja) 蛋白質イソプレニルトランスフェラーゼの阻害剤
US5703097A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
US4248880A (en) Treatment of gastric ulcers with naphthimidazole derivatives
EP0042544B1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
EP0208452B1 (en) Pyridine derivatives, their production and use
IE58363B1 (en) Pyridine derivatives and their production
WO2000009498A1 (en) Prodrugs of proton pump inhibitors
JPH05247035A (ja) ピリジン誘導体及びそれを含有する潰瘍治療剤
NO164473B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler.
KR910002824B1 (ko) 피리딘유도체 및 그것을 함유하는 궤양치료제
KR0142815B1 (ko) 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
KR930004843B1 (ko) 이미다졸 유도체 및 이의 제조방법
US4777172A (en) Pyrimidylalkylthio benzimidale compounds, pharmaceutical compositions and use
KR950001015B1 (ko) 술폭시드 유도체의 제조방법
EP0481764B1 (en) Pyridine derivatives, their production and use
US5250527A (en) Pyridyl containing benzimidazoles, compositions and use
US4497810A (en) Thiatriazine dioxides as gastric anti-secretory agents
SU1362402A3 (ru) Способ получени производных имидазола или их солей с кислотами
US4859679A (en) Antiulcer (alkyldithio) quinoline derivatives
EP0246774A1 (en) Chemical compounds
IE843118L (en) Imidazoquinolines and related heterocyclics
US4187303A (en) Thiazine derivatives
EP0194458B1 (en) New indole derivatives, the production and uses thereof
FI80458C (fi) Foerfarande foer framstaellning av . terapeutiskt anvaendbara tiazolo/3,2-a/bensimidazoler och 2,3-dihydroanaloger daerav.

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19960228

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19960228